Sa. Brod et al., DECREASED CD3-MEDIATED INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Annals of neurology, 37(4), 1995, pp. 546-549
Multiple sclerosis (MS) is a chronic inflammatory disease of the centr
al nervous system that has been postulated to be T-cell mediated. We e
xamined the proliferation and cytokine secretion of mononuclear cells
after stimulation with OKT3 (anti-CD3) monoclonal antibody concanavali
n A, or ionomycin plus myristic acid palmityl ester in subjects with s
table relapsing-remitting MS. Control subjects demonstrated good proli
feration to anti-CD3 monoclonal antibody whereas subjects with relapsi
ng-remitting MS showed a significantly decreased anti-CD3 monoclonal a
ntibody-mediated response. There was no difference in concanavalin or
ionomycin plus myristic acid palmityl ester stimulation between contro
l subjects and MS subjects. Secretion of interferon-gamma was signific
antly decreased and transforming growth factor-beta was significantly
increased from cultures stimulated with anti-CD3 monoclonal antibody,
but not ionomycin plus myristic acid palmityl ester or concanavalin A,
in MS patients compared to control subjects. Secretion of interleukin
-10 and tumor necrosis factor-alpha was not different between control
subjects and MS patients following stimulation with anti-CD3 monoclona
l antibody, concanavalin A, or ionomycin plus myristic acid palmityl e
ster, or of interleukin-2 and interleukin-4 following stimulation with
anti-CD3 monoclonal antibody or concanavalin A. An abnormality of sig
nal transduction and secretion of the immuno-modulatory molecule inter
feron-gamma may exist in MS via the CD3 T-cell receptor complex.